Summary
Parkinson’s disease is a common neurodegenerative disease with complex clinical features. Recently, we idenfied a novel gene named Parkin to be responsible for the pathogenesis of autosomal recessive juvenile parkinsonism (AR-JP). Various mutations were found in AR-JP patients of Japanese and other ethnic origins, providing a definitive evidence for the Parkin to be a causative gene for AR-JP. The predicted structure of Parkin protein and its mutation provide important clues for studying the functional role of the Parkin protein in leading to selective degeneration of nigral neurons in the brains of AR-JP patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Asakawa S, Abe I, Kudoh Y, Kishi N, Wang Y, Kubota R, Kudoh J, Kawasaki K, Minoshima S, Shimizu N (1997) Human BAC library: construction and screening. Gene 191: 69–79
Calne D.B., Langston J.W. (1983) Aetiology of Parkinson’s disease. Lancet ii: 1457–1459
Ciechanover, A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79: 13–21
Finley D, Bartel B, Varshavsky A (1989) The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature 338: 394–401
Galloway P.G., Mulvihill P, Perry G (1992) Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 140: 809–822
Gasser T (1998) Genetics of Parkinson’s disease. Ann Neurol 44 [Suppl 1]: s53–s57
Gregori L, Poosch M.S., Cousins G, Chau V (1990) A uniform isopeptide-linked multiubiquitin chain is sufficient to target substrate for degradation in ubiquitinmediated proteolysis. J Biol Chem 265: 8354–8357
Gregori L, Fuchs C, Figueiredo-Pereira M.E., Van Nostrand W.E., Goldgaber D (1995) Amyloid b-protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem 270: 19702–19708
Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Kondo T, Kuzuhara S, Nakamura S, Shimizu N, Mizuno Y (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with AR-JP: evidence for variable homozygous deletions in the parkin gene in affected individuals. Ann Neurol 44: 935–941
Hattori N, Matsumine H, Asakawa S, Kitada T, Yoshino H, Elibol B, Brrokes A.J., Yamamura Y, Kobayashi T, Wang M, Yoritaka A, Minoshima S, Shimizu N, Mizuno Y (1998) Point mutations (Thr240Arg and Gln311Stop) in the Parkin gene. Biophys Res Commun 249: 754–758
Hochstrasser M (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7: 215–223
Ishikawa A, Tsuji S (1996) Clinical analysis of 17 patients in 12 Japanese families with autosomal recessive type juvenile parkinsonism. Neurology 47: 160–169
Iwatsubo T, Yamaguchi H, Fujimuro M, Yokosawa H, Ihara Y, Trojanowski J.Q., Lee V.W. (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148: 1517–1529
Jenner P, Schapira A.H.V., Marsden C.D. (1992) New insights into the cause of Parkinson’s disease. Neurology 42: 2241–2250
Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605–608
Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen J.T., Schols L, Reiss O (1998) Ala30Pro mutation in the gene encoding a-synuclein in Parkinson’s disease, Nature Genet 18: 106–108
Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein M.J., Jonnalagada S, Chemova T, Dehejia A, Lavedan C, Gasser T, Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. (1998a) The ubiquitin pathway in Parkinson’s disease. Nature 395: 451–452
Leroy E, Anastasopoulos D, Konistsiotis S, Lavedan C, Polymeropoulos M.H. (1998b) Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson’s disease. Hum Genet 103: 424–427
Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, Nakagawa-Hattori Y, Yokochi M, Kobayashi T, Igarashi S, Takano H, Sanpei K, Koike R, Mori H, Kondo T, Mizutani Y, Schaffer A.A., Yamamura Y, Nakamura S, Kuzuhara S, Tsuji S, Mizuno Y (1997) Localization of a gene for autosomal rcessive form of juvenile parkinsonism (AR-JP) to chromosome 6q25.2-27. Am J Hum Genet 60:588–596
Matsumine H, Yamamura Y, Hattori N, Kobayashi T, Kitada T, Yoritaka A, Mizuno Y (1998) A microdeletion of D6S305 in a family of autosomal recessive juvenile parkinsonism (PARK2). Genomics 49: 143–146
Mezey E, Dehejia A, Harta G, Papp M.I., Polymeropoulos M.H., Brownstein M.J. (1998) Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nature Med 4: 755–757
Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer’s disease. Science 235: 1641–1644
Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K, Ihara Y (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10: 1151–1160
Parkinson J (1817) An essay on the shaking palsy. Whittingham and Rowland, London
Pinna LA (1990) Casein kinase 2: An “eminence grise” in cellular regulation? Biochim Biophys Acta 1054: 267–284
Polymeropoulos M.H., Higgins J.J., Golbe L.I., Johnson W.G., Ide S.E., Di Iorio G, Stenroos ES, Pho L.T., Schaffer A.A., Lazzrini A.M., Nussbaum R.L., Duvoisin R.C. (1996) Mapping of a gene for Parkinson’s disease to chromosome 4q21–q23. Science 274: 1197–1199
Polymeropoulos M.H., Lavedan C, Laroy E, Ide S.E., Dehejia A, Pike A.D.B., Root H, Rubenstein J, Boyer R, Stenroos E.S., Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Irio G, Globe L.I., Nussbaum R.L. (1997) Mutations in the a-synuclein gene identified in families with Parkinson’s disease. Science 276: 2045–2047
Riess O, Jakes R, Kruger R (1998) Genetic dissection of familial Parkinson’s disease. Mol Med Today October: 438–444
Shimizu N (1999) Human genome project: current status, Keio strategy, and prospects. In: Uyemura K, Kawamura K, Yazaki T (eds) Keio University Symposium for Life Science and Medicine, vol 2. Neural development. Springer, Berlin Heidelberg New York Tokyo, pp 535–540
Shimura H, Hattori N, Kubo S, Yoshikawa M, Kitada T, Matsumine H, Asakawa S, Minoshima S, Yamamura Y, Shimizu N, Mizuno Y (1999) Immunohistochemical and subcellular localization of parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol 45: 668–672
Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, Tsuji S, Ikuta F (1994) Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44: 437–441
Yamamura Y, Arihiro K, Hohriyama T, Nakamura S (1993) Early-onset parkinsonism with diurnal fluctuation-clinical and pathological studies. Clin Neurol (Tokyo) 33:491–496
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this paper
Cite this paper
Shimizu, N. et al. (2000). PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism. In: Mizuno, Y., Calne, D.B., Horowski, R., Poewe, W., Riederer, P., Youdim, M.B.H. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6284-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6284-2_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7246-9
Online ISBN: 978-3-7091-6284-2
eBook Packages: Springer Book Archive